Independently tested/Batch-level documentation
Batch record

BLD-502

BPC-157/TB-500 Blend · View product

Product
BPC-157/TB-500 Blend
Batch number
BLD-502
Date tested
November 5, 2026
Testing laboratory
Peptide Test Canada / Side-Chain Analytics Inc.
Identity result
Reported components: BPC-157 and Thymosin β4 (HPLC-MS/MS).
Quantity result
BPC-157: 12.14 mg; Thymosin β4: 11.85 mg; total net content: 23.99 mg (tested sample).
Purity result
BPC-157: 99.71%; Thymosin β4: 99.70% chromatographic purity (tested sample).
Additional testing
No endotoxin or sterility results supplied.
Tests performed
HPLC-MS/MS identity analysis, Quantitative peptide content, Chromatographic purity

Laboratory sample ID BLD-502; report COA-2026-SC-04742; verification reference PTC-87JHUVCY. Received October 29, 2026; analyzed and reported November 5, 2026. This record uses the laboratory sample ID, not a confirmed inventory lot number. The laboratory names the second component Thymosin β4. Results apply only to the sample as received, not other vials or any entire lot or batch. They do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use. Laboratory permission to display the full report was confirmed by the owner.

Analytical results describe only the sample tested by the named laboratory on the stated date, not other vials or an entire lot or batch. Endotoxin testing is not a sterility test. These results do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use.